|
BALTIMORE, MD—August 12, 2014—The Indiana University School of Medicine and Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), are pleased to announce the availability of a complimentary, CME-certified Webcast in type 2 diabetes.
The inhibition of renal glucose reabsorption is now another mechanism by which physicians can modulate blood glucose levels among their patients with type 2 diabetes. Because the United States Food and Drug Administration recently approved the first agent in this class, the Indiana University School of Medicine and Med-IQ have designed the CME activity, SGLT2 Inhibition in Type 2 Diabetes: Understanding the Rationale and Incorporating New Approaches Into Practice, to address the many mechanism- and practice-related questions that clinicians may have as they explore the rationale for this novel therapeutic approach and how clinical trial data can be applied to real-world settings.
“This educational activity is designed to assist healthcare providers in exploring and better understanding the role of the kidney in glucose homeostasis,” said Vivian Fonseca, MD, Professor of Medicine and Pharmacology, at Tulane University Health Sciences Center in New Orleans. “Participants will also have the opportunity to review recent clinical evidence on SGLT2 inhibitors and how they can be integrated into the management of type 2 diabetes.”
FACULTY
 |
|
Vivian Fonseca, MD
Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA
|
 |
|
Mark Stolar, MD
Associate Professor of Clinical Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL
|
PEER REVIEWER
 |
|
Melissa K. Cavaghan, MD
Associate Professor of Clinical Medicine
Division of Endocrinology and Metabolism
Indiana University School of Medicine
Indianapolis, IN
|
Med-IQ is pleased to be collaborating with Indiana University School of Medicine’s nationally renowned Division of CME to achieve the goal of providing clinicians with quality educational activities designed to improve patient outcomes.
Clinicians are invited to visit www.Med-IQ.com/a771 for complimentary access to this educational opportunity. For more information, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com.
This activity has been approved for AMA PRA Category 1 Credit™ by Indiana University School of Medicine and is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
|
|
About Indiana University School of Medicine
Indiana University School of Medicine (IUSM), as both a premier medical institution and the second largest medical school in the nation, is committed to providing the highest healthcare locally and nationally by promoting innovation and excellence in education, research and patient care. The IUSM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians with Accreditation with Commendation through November 2017. Promoting excellence in physician professional development and effectively translates leading-edge research into medical practice, the mission of the Indiana University School of Medicine’s Division of Continuing Medical Education (IUSM CME) is to provide lifelong learning opportunities designed to increase knowledge and competence and, to the fullest extent possible, to enhance the ability of physicians and other health care professionals to improve their performance and/or to improve patient- and systems-level outcomes.
|
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management to improve team performance and patient outcomes. These initiatives have achieved improvements in healthcare provider performance, quality of care, and patient outcomes. Med-IQ's work in performance and quality education and training has been published 27 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
|
close
